Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.

Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M.

Dis Markers. 2013;35(4):207-12. doi: 10.1155/2013/761537. Epub 2013 Sep 3.


Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.

Obacz J, Pastorekova S, Vojtesek B, Hrstka R.

Mol Cancer. 2013 Aug 14;12(1):93. doi: 10.1186/1476-4598-12-93. Review.


Impaired pre-mRNA processing and altered architecture of 3' untranslated regions contribute to the development of human disorders.

Michalova E, Vojtesek B, Hrstka R.

Int J Mol Sci. 2013 Jul 26;14(8):15681-94. doi: 10.3390/ijms140815681. Review.


Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Brázdová M, Navrátilová L, Tichý V, Němcová K, Lexa M, Hrstka R, Pečinka P, Adámik M, Vojtesek B, Paleček E, Deppert W, Fojta M.

PLoS One. 2013;8(3):e59567. doi: 10.1371/journal.pone.0059567. Epub 2013 Mar 26.


Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2.

Hrstka R, Murray E, Brychtova V, Fabian P, Hupp TR, Vojtesek B.

Cancer Lett. 2013 Jun 10;333(2):187-93. doi: 10.1016/j.canlet.2013.01.034. Epub 2013 Jan 24.


Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.

Chevet E, Fessart D, Delom F, Mulot A, Vojtesek B, Hrstka R, Murray E, Gray T, Hupp T.

Oncogene. 2013 May 16;32(20):2499-509. doi: 10.1038/onc.2012.346. Epub 2012 Sep 3. Review.


C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.

Muller P, Ruckova E, Halada P, Coates PJ, Hrstka R, Lane DP, Vojtesek B.

Oncogene. 2013 Jun 20;32(25):3101-10. doi: 10.1038/onc.2012.314. Epub 2012 Jul 23.


Supplemental Content

Loading ...
Support Center